Efficacy and safety of dapagliflozin in the treatment of chronic heart failure: A protocol for systematic review and meta-analysis

BACKGROUND: As the last link in the chain of cardiovascular events, chronic heart failure (CHF) has high morbidity, high mortality, and poor prognosis. It is one of the main causes of death and disability worldwide. As a new drug for the treatment of chronic cardiovascular disease, dapagliflozin, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xueyan, Ren, Lili, Liu, Yueli, Yin, Xuewei, Cui, Siyuan, Gao, Wulin, Yu, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257897/
https://www.ncbi.nlm.nih.gov/pubmed/34190162
http://dx.doi.org/10.1097/MD.0000000000026420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257897/
https://www.ncbi.nlm.nih.gov/pubmed/34190162
http://dx.doi.org/10.1097/MD.0000000000026420

Ejemplares similares